ArticleThe Annals of pharmacotherapy2013
Delivery of optimized inpatient anticoagulation therapy: consensus statement from the anticoagulation forum.
Article in The Annals of pharmacotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 55 citations in OpenAlex.
- Impact of pharmacist-conducted anticoagulation patient education and telephone follow-up on transitions of care: a randomized controlled trial.BMC health services research · 2021Trial
- Antiphospholipid Antibody Syndrome and Cardiogenic Shock: A Fatal Intersection.JACC. Case reports · 2026Article
- Knowledge, attitude and practice towards oral anticoagulants: a cross-sectional study among healthcare professionals in Nigeria.BMC primary care · 2026Article
- Exploring stakeholder perceptions of implementing a pharmacist-led anticoagulation clinic in primary care settings: a cross-sectional study.Journal of pharmaceutical policy and practice · 2024Article
- Comparison of two escalated enoxaparin dosing regimens for venous thromboembolism prophylaxis in obese hospitalized patients.Journal of thrombosis and thrombolysis · 2021Article
- Uptake and Utilization of the Management of Anticoagulation in the Periprocedural Period App: Longitudinal Analysis.JMIR mHealth and uHealth · 2018Article
- Role of the anticoagulant monitoring service in 2018: beyond warfarin.Hematology. American Society of Hematology. Education Program · 2018Review
- An evidence-based standardized protocol for anticoagulation following congenital heart surgery.Translational pediatrics · 2018Article
- Preemptive warfarin dose reduction after initiation of sulfamethoxazole-trimethoprim or metronidazole.Journal of thrombosis and thrombolysis · 2017Article
- Meaningful use of health information technology and declines in in-hospital adverse drug events.Journal of the American Medical Informatics Association : JAMIA · 2017Article
- Implications of an inpatient warfarin dosing nomogram on safety outcomes post-discharge.Journal of thrombosis and thrombolysis · 2017Article
- The scope and value of an anticoagulation stewardship program at a community teaching hospital.Journal of thrombosis and thrombolysis · 2017Article
- Anticoagulation manager: development of a clinical decision support mobile application for management of anticoagulants.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2016Article
- Regulatory, legislative, and policy updates with anticoagulant use.Journal of thrombosis and thrombolysis · 2015Review
- Anticoagulants and acute kidney injury: clinical and pathology considerations.Kidney research and clinical practice · 2014Review
- [New oral anticoagulants in perioperative medicine].Der Anaesthesist · 2014Article
- Impact of target-specific oral anticoagulants on transitions of care and outpatient care models.Journal of thrombosis and thrombolysis · 2013Review
- The future of inpatient anticoagulation management.Journal of thrombosis and thrombolysis · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 5 institutions in 2 countries.
Funding
Abstract
objectiveTo provide recommendations for optimized anticoagulant therapy in the inpatient setting and outline broad elements that need to be in place for effective management of anticoagulant therapy in hospitalized patients; the guidelines are designed to promote optimization of patient clinical outcomes while minimizing the risks for potential anticoagulation-related errors and adverse events. DATA SOURCES: The medical literature was reviewed using MEDLINE (1946-January 2013), EMBASE (1980-January 2013), and PubMed (1947-January 2013) for topics and key words including, but not limited to, standards of practice, national guidelines, patient safety initiatives, and regulatory requirements pertaining to anticoagulant use in the inpatient setting. Non-English-language publications were excluded. Specific MeSH terms used include algorithms, anticoagulants/administration and dosage/adverse effects/therapeutic use, clinical protocols/standards, decision support systems, drug monitoring/methods, humans, inpatients, efficiency/ organizational, outcome and process assessment (health care), patient care team/organization and administration, program development/standards, quality improvement/organization and administration, thrombosis/ drug therapy, thrombosis/prevention and control, risk assessment/standards, patient safety/standards, and risk management/methods. STUDY SELECTION AND DATA EXTRACTION: Because of this document's scope, the medical literature was searched using a variety of strategies. When possible, recommendations are supported by available evidence; however, because this paper deals with processes and systems of care, high-quality evidence (eg, controlled trials) is unavailable. In these cases, recommendations represent the consensus opinion of all authors and are endorsed by the Board of Directors of the Anticoagulation Forum, an organization dedicated to optimizing anticoagulation care. The board is composed of physicians, pharmacists, and nurses with demonstrated expertise and experience in the management of patients receiving anticoagulation therapy. DATA SYNTHESIS: Recommendations for delivering optimized inpatient anticoagulation therapy were developed collaboratively by the authors and are summarized in 8 key areas: (1) process, (2) accountability, (3) integration, (4) standards of practice, (5) provider education and competency, (6) patient education, (7) care transitions, and (8) outcomes. Recommendations are intended to inform the development of coordinated care systems containing elements with demonstrated benefit in improvement of anticoagulation therapy outcomes. Recommendations for delivering optimized inpatient anticoagulation therapy are intended to apply to all clinicians involved in the care of hospitalized patients receiving anticoagulation therapy.
conclusionsAnticoagulants are high-risk medications associated with a significant rate of medication errors among hospitalized patients. Several national organizations have introduced initiatives to reduce the likelihood of patient harm associated with the use of anticoagulants. Health care organizations are under increasing pressure to develop systems to ensure the safe and effective use of anticoagulants in the inpatient setting. This document provides consensus guidelines for anticoagulant therapy in the inpatient setting and serves as a companion document to prior guidelines relevant for outpatients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.